alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF JUNE 30, 1999 AND THE INCOME STATEMENT FOR THE SIX MONTHS ENDED JUNE
30, 1999, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                              30
<SECURITIES>                                         0
<RECEIVABLES>                                      192
<ALLOWANCES>                                         0
<INVENTORY>                                        224
<CURRENT-ASSETS>                                   515
<PP&E>                                             245
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,332
<CURRENT-LIABILITIES>                              442
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       (324)
<TOTAL-LIABILITY-AND-EQUITY>                     1,332
<SALES>                                          1,216
<TOTAL-REVENUES>                                 1,216
<CGS>                                              867
<TOTAL-COSTS>                                      867
<OTHER-EXPENSES>                                   269
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  53
<INCOME-PRETAX>                                     22
<INCOME-TAX>                                        13
<INCOME-CONTINUING>                                  9
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         9
<EPS-BASIC>                                     0.23
<EPS-DILUTED>                                     0.21


</TABLE>
<PAGE>


                                                                    Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Belden & Blake Corporation
(the "Company") on Form 10-Q for the quarterly period ended June 30, 2003, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), the undersigned, in the capacities and on the dates indicated below,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the knowledge of the
undersigned:

         1.    The Report fully complies with the requirements of Section 13(a)
               or 15(d) of the Securities Exchange Act of 1934; and

         2.    The information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.






Date:    August 12, 2003                   /s/ John L. Schwager
     --------------------                 ------------------------------------
                                          John L. Schwager, Director, President
                                          and Chief Executive Officer

This certification accompanies the Form 10-Q and shall not be treated as having
been filed as part of the Form 10-Q.




                                       28
#### State v. Dowler

16286

12/4/95

Granted

— Hawai'i — - P.2d -
Ministerial Meeting to Discuss the U.S. EPA Notice of Data Availability Concerning Renewable Fuels 

Produced from Palm Oil

Meeting Date: Friday, March 23

Building: RRB, OITA Fishbowl, RRB 3rd Floor

Time: 9:45 (arrive)- 10:45 AM

1. List of Delegation from Malaysia for the Meeting with Assistant Administrator for EPA

Name Designation

1

Tan Sri Bernard 

Dompok

Minister of Plantation 

Industries and Commodities

2 Mr. M. Nagarajan Deputy Secretary General

3 Dr. Choo Yuen May Director General of Malaysian 

Palm Oil Board (MPOB)

4 Dr. Yusof Bin Basiron CEO, Malaysian Palm Oil 

Council

5 Dr. Lim Weng Soon Director of processing and 

Engineering, MPOB

6 Rosidah Radzian Regional Manager/Science 

Attaché

7

Dayang Ratnasari 

Binti Abu Bakar Assistant Secretary

8. Dr. Phua Chiew Wei Scientist

2. List of Delegation from Indonesia – for Meeting with Assistant Administrator of EPA

Name Designation

1

Dr. Zaenal 

Bachruddin

Director General of 

Processing and Marketing 

Ag. Products

2 Dr. Dino Patti Djalal Ambassador

3

Dr. Rosediana 

Suharto

Executive Chairperson of 

Indonesia Palm Oil 

Commission

4 Mr. Mesah Tarigan Director of International 

Marketing Development

3. Representative form Hudson & Knight LLP
- Mr. Kurt Blasé, Partner of Holland & Knight, LLP

 (Nationality – American)

4. List of Representatives from U.S. EPA

Gina McCarthy, Assistant Administrator, Office of Air and Radiation

Margo T. Oge, Director, Office of Transportation and Air Quality

Karl Simon, Director, Transportation and Climate Division

Benjamin Hengst, Assistant Director, Transportation and Climate Division

Sharyn Lie, Director, Climate and Economic Modeling Center

Aaron Levy, Transportation and Climate Division

Pam Teel, Office of International and Tribal Affairs

Marta Montoro, Office of Air and Radiation
Item_5_1_9a_Camelpox/ page 1

Annex 33

CHAPTER ~~X~~16.Z.INFECTION WITH CAMELPOX VIRUS

Article ~~X~~16.Z.1.

General provisions

For the purposes of the *Terrestrial Code*, *infection* with camelpox virus is defined as an *infection* of dromedary and bactrian camels (hereafter ‘susceptible animals’) with ~~c~~*Camelpox virus*~~of genus *Orthopoxvirus*, family *Poxviridae*~~.

The following defines the occurrence of *infection* with ~~c~~*Camelpox virus*:

1)	~~c~~*Camelpox virus* has been isolated and identified as such in a sample from a susceptible animal; or 

2)	characteristic orthopox virions have been observed in a sample from a susceptible animal showing clinical signs ~~suggestive of~~consistent with *infection* with ~~c~~*Camelpox virus* or epidemiologically linked to a confirmed or suspected *case*; or 

3)	antigen or nucleic acid specific to ~~c~~*Camelpox virus* has been detected in a sample from a susceptible animal showing clinical signs ~~suggestive of~~consistent with *infection* with ~~c~~*Camelpox virus*, or epidemiologically linked to a confirmed or suspected *case*; or

4)	antibodies specific to ~~c~~*Camelpox virus*, that are not the consequence of *vaccination*, have been detected in a sample from a susceptible animal showing clinical signs ~~suggestive of~~consistent with *infection* with ~~c~~*Camelpox virus*, or epidemiologically linked to a confirmed or suspected *case*.

Standards for diagnostic tests and vaccines are described in the *Terrestrial Manual*. 

___________________________

*WOAH Terrestrial Animal Health Standards Commission/September 2022*

Report of the Meeting of the WOAH Terrestrial Animal Health Standards Commission/February 2023	1
# C_2018445EN.01001001.xml

| 10.12.2018 | EN | Official Journal of the European Union | C 445/10 |
| --- | --- | --- | --- |

10.12.2018

EN

Official Journal of the European Union

C 445/10

---

Reference for a preliminary ruling from the Court of Session, Edinburgh (United Kingdom) made on 3 October 2018 — Andy Wightman and Others v Secretary of State for Exiting the European Union

(Case C-621/18)

(2018/C 445/12)

Language of the case: English

Referring court

Court of Session, Edinburgh

Parties to the main proceedings

Applicants: Andy Wightman, Ross Greer, Alyn Smith, David Martin, Catherine Stihler, Jolyon Maugham, Joanna Cherry

Defendant: Secretary of State for Exiting the European Union

Other parties to the procedure: Chris Leslie, Tom Brake

Question referred

Where, in accordance with Article 50 of the Treaty on European Union, a Member State has notified the European Council of its intention to withdraw from the European Union, does EU law permit that notice to be revoked unilaterally by the notifying Member State; and, if so, subject to what conditions and with what effect relative to the Member State remaining within the European Union?

---
EXHIBIT 99.1




                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                      AS ADOPTED PURSUANT TO SECTION 906 OF
                         THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of FGIC Securities  Purchase,  Inc. (the
"Company")  on Form 10-Q for the period  ending  June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Deborah
M. Reif, Chief Executive  Officer of the Company,  hereby certify pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that:

          (1)       the Report fully complies with the  requirements  of Section
                    13(a) or 15(d) of the Securities Exchange Act of 1934; and

          (2)       the information  contained in the Report fairly presents, in
                    all material respects,  the financial  condition and results
                    of operations of the Company.






                                               /s/ Deborah M. Reif
                                               ---------------------------
Date: August 14, 2002                          Deborah M. Reif
                                               Chief Executive Officer


<PAGE>
# C_2020010EN.01003102.xml

| 13.1.2020 | EN | Official Journal of the European Union | C 10/31 |
| --- | --- | --- | --- |

13.1.2020

EN

Official Journal of the European Union

C 10/31

---

Judgment of the General Court of 7 November 2019 — WN v Parliament

(Case T-431/18) (1)

(Civil service - Accredited parliamentary assistants - Early termination of the contract - Breakdown in the relationship of trust - Rights of defence - Conciliation procedure - Manifest error of assessment - Discrimination on grounds of sex - Maternity leave - Duty to have regard for the welfare of officials)

(2020/C 10/42)

Language of the case: English

Parties

Applicant: WN (represented by: L. Levi and A. Champetier, lawyers)

Defendant: European Parliament (represented by: Í. Ní Riagáin Düro and M. Windisch, acting as Agents)

Re:

Application under Article 270 TFEU for, first, annulment of the Parliament’s decision of 28 September 2017 to terminate the applicant’s contract as an accredited parliamentary assistant and, secondly, compensation for the non-material damage she allegedly suffered as a result of the Parliament’s conduct.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders each party to bear its own costs. |
| --- | --- |

2.

Orders each party to bear its own costs.

---

(1)  OJ C 319, 10.9.2018.

---
#### State v. Kuamoo

15480

4/13/92

Granted
Page 1 of 2

Veterinary Health Certificate for Transit of Commercial Birds through the United States 

Veterinary Authority Date of Issue Certificate Number 

CERTIFICATION

This is to certify that the animals described herein conform to the veterinary import requirements of the United States. 

Health certificates are valid for 30 days from the date of endorsement by the competent authority.

1. Consignor/Shipper/Owner: 2. Consignee/Broker/Owner:

3. Country of Export: 4. Date of Shipment:

5. Country of Destination: 6.State of Destination:

7. Home Quarantine Address: 8. Port of Embarkation / Border Crossing:

9. Date of Veterinary Inspection: 10. Means of Transport:

11. Description of Commodity:

Commercial Birds 

12. Commodities Intended Use:

Commercial 

13. Total Quantity: 14. Total Number of Shipping Containers:

Note: Shipments consisting of 5 or less birds are considered as “pets.” 

There is no identification requirement for commercial bird transits.

Bottom of page intentionally left blank
Page 2 of 2

Veterinary Health Certificate for Transit of Commercial Birds through the United States 

Veterinary Authority Date of Issue Certificate Number 

The issuing /official veterinarian certifies that all birds covered by this certificate have been 

inspected and attests to the following statements: 

1. The veterinarian issuing the certificate completed inspection and testing of the birds covered under this health

certificate.

2. The bird(s) was/were not vaccinated against any H5 or H7 subtype of avian influenza.

3. The veterinarian issuing the certificate examined the bird(s) within 30 days prior to export, and saw no evidence

of communicable diseases of birds.

4. The bird(s) covered by this certificate do not originate from flocks nor had contact with any birds or poultry

originating in a control zone established by state/provincial/federal animal health authorities due to outbreaks of

Newcastle disease or Highly Pathogenic Avian Influenza (HPAI) in the 90 days preceding the exportation.

5. CHOOSE EITHER OPTION A OR B BELOW:

A. The bird(s) was/were not vaccinated against Newcastle disease

OR

B. The bird(s) were vaccinated against Newcastle disease (avian paramyxovirus) at least 21 days prior to

export, using vaccines that do not contain any velogenic strains of Newcastle disease virus.

Vaccine Name:

Date:

6. The shipment will not transit through any region where APHIS considers highly pathogenic avian influenza to

exist.

7. Birds must be inspected within 24 hours of export.

8. The birds were placed in new or appropriately sanitized packaging materials at the premises from which the

birds were to be exported.

**********************Certificate shall be valid for 30 days from date of issue************************

The official veterinarian must endorse the issuing veterinarian’s signature OR the official veterinarian’s 

signature and government seal is used alone. 

Name of Issuing Veterinarian (Printed) Name of Official Veterinarian (Printed) 

Signature of Issuing Veterinarian Signature of Official Veterinarian

Date Date
#### State v. Dicus

16783

4/24/95

Affirmed
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

444444444444444

NO. 03-04-00701-CV

444444444444444

Texas Department of Public Safety, Appellant

v.

Randall Dacey, Appellee

44444444444444444444444444444444444444444444444444444444444444444

FROM THE DISTRICT COURT OF COMAL COUNTY, 207TH JUDICIAL DISTRICT

NO. C2004-0332B, HONORABLE JACK H. ROBISON, JUDGE PRESIDING

44444444444444444444444444444444444444444444444444444444444444444

M E M O R A N D U M O P I N I O N

Appellant Texas Department of Transportation filed a motion to dismiss this appeal.

Accordingly, we grant the motion to dismiss this appeal. See Tex. R. App. P. 42.1(a)(1).

__________________________________________

Bob Pemberton, Justice

Before Chief Justice Law, Justices B. A. Smith and Pemberton

Dismissed on Appellant’s Motion

Filed: January 18, 2005
Annex 4A

**USA COMMENTS IN RED FONT**

**GLOSSARY**

For the purposes of the *Terrestrial Code*:

[...]

***POULTRY***

means all birds reared or kept in captivity for the production of any commercial animal products or for breeding for this purpose, fighting cocks used for any purpose, and all birds used for restocking supplies of game or for breeding for this purpose, until they are released from captivity. 

Birds that are kept in a single household, the products of which are used primarily within the same household ~~exclusively~~, are not considered poultry, provided that they have no direct or indirect contact with poultry or poultry facilities. 

Birds that are kept in captivity for other reasons, including those that are kept for shows, racing, exhibitions, zoological collections and competitions, and for breeding or selling for these purposes, as well as pet birds, are not considered poultry, provided that they have no direct or indirect contact with poultry or poultry facilities. means all birds reared or kept in captivity for the production of any commercial animal products or for breeding for this purpose,fighting cocks used for any purpose, and all birds used for restocking supplies of game or for breeding for this purpose, until they are released from captivity.

**RATIONALE:** Epidemiologic investigations of HPAI outbreaks around the world have shown that HPAI-affected household flocks pose little risk of transmission of the virus to commercial poultry flocks that are likely to provide products for international trade. Commonly, families keeping household flocks will occasionally share eggs with their local community. Changing the definition to acknowledge this ubiquitous, inconsequential activity removes a burden from animal health officials to prove that products from an HPAI-affected flock have never been used outside of a household and preserves the intent of the original definition to prevent low-risk household agricultural activity from interfering with safe international trade of poultry and poultry products.

In addition to the risk analysis studies referenced below, the USA recognizes that the WOAH may determine an additional risk analysis by subject matter experts is needed to validate this proposed change to the definition of *poultry* in the Glossary.

References:

1) The role of backyard poultry flocks in the epidemic of highly pathogenic avian influenza virus (H7N7) in the Netherlands in 2003 - ScienceDirect.

2) The Pennsylvania/Virginia Experience in Eradication of Avian Influenza (H5N2) on JSTOR.

3) Role of Backyard Flocks in Transmission Dynamics of Highly Pathogenic Avian Influenza A(H5N8) Clade 2.3.4.4, France, 2016–2017 - PMC (nih.gov).

4) How backyard poultry flocks influence the effort required to curtail avian influenza epidemics in commercial poultry flocks – ScienceDirect.

[...]

*OIE Terrestrial Animal Health Standards Commission/February 2022*1
# C_2018190EN.01001401.xml

| 4.6.2018 | EN | Official Journal of the European Union | C 190/14 |
| --- | --- | --- | --- |

4.6.2018

EN

Official Journal of the European Union

C 190/14

---

Request for a preliminary ruling from the Cour de cassation (France) lodged on 29 March 2018 — GRDF SA v Eni Gas & Power France SA, Direct énergie, Commission de régulation de l’énergie, Procureur général près la Cour d’appel de Paris

(Case C-236/18)

(2018/C 190/19)

Language of the case: French

Referring court

Referring court

Cour de cassation

Parties to the main proceedings

Parties to the main proceedings

Appellant: GRDF SA

Appellant:

Respondents: Eni Gas & Power France SA, Direct énergie, Commission de régulation de l’énergie, Procureur général près la Cour d’appel de Paris

Respondents:

Question referred

Question referred

Is Directive 2009/73/EC of the European Parliament and of the Council of 13 July 2009, (1) and in particular Article 41(11) thereof, to be interpreted as requiring that a regulatory authority, when settling a dispute, must have power to issue a decision which applies to the whole of the period to which that dispute relates, regardless of the date on which that dispute arose between the parties, in particular by drawing the consequences of the non-conformity of a contract with the provisions of the directive by means of a decision taking effect as regards the whole of the contractual period?

1

---

(1)  Directive 2009/73/EC of the European Parliament and of the Council of 13 July 2009 concerning common rules for the internal market in natural gas and repealing Directive 2003/55/EC (OJ 2009 L 211, p. 94).

1

---
Exhibit 32.01




CERTIFICATION OF CHIEF EXECUTIVE OFFICER REQUIRED BY
RULE 13a-14(b) or RULE 15d-14(b) AND SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350




In connection with the Annual Report of Williams Controls,
Inc (the Company) on Form 10-K for the period ended September 30, 2005 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Patrick W. Cavanagh, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:


|(1) |  | The Report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the Company.
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



/s/ PATRICK W. CAVANAGH Patrick W. Cavanagh Chief Executive Officer Williams Controls, Inc December 7,
2005


---
<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                         740,085
<SECURITIES>                                 3,026,520
<RECEIVABLES>                                3,376,763
<ALLOWANCES>                                    13,000
<INVENTORY>                                    373,891
<CURRENT-ASSETS>                             7,845,559
<PP&E>                                       1,410,770
<DEPRECIATION>                                 513,089
<TOTAL-ASSETS>                              11,852,108
<CURRENT-LIABILITIES>                        2,302,243
<BONDS>                                        142,855
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        43,425
<OTHER-SE>                                   9,207,668
<TOTAL-LIABILITY-AND-EQUITY>                11,852,108
<SALES>                                     10,313,014
<TOTAL-REVENUES>                            10,313,014
<CGS>                                        5,472,254
<TOTAL-COSTS>                                5,472,254
<OTHER-EXPENSES>                             3,516,541
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,165
<INCOME-PRETAX>                              1,520,197
<INCOME-TAX>                                  (34,000)
<INCOME-CONTINUING>                          1,554,197
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,554,197
<EPS-PRIMARY>                                      .36
<EPS-DILUTED>                                      .36
        

</TABLE>
#### Norva v. Edralin

22702

04/18/2001

Affirmed in part, Vacated in part & Remanded
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Indevus Pharmaceuticals, Inc. (the Company) on
Form 10-K/A for the period ended September 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Glenn L. Cooper, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|    |  |                        
|--- |  | -----------------------
|By: |  | /s/ Glenn L. Cooper    
|    |  | Chief Executive Officer
|    |  | January 26, 2007